Global Prostate Cancer Market size likely to grow at 9.5% CAGR from 2016 to 2021
A latest report by Marketdataforecast.com on Global Prostate Cancer Market provides information on market size, share, forecast and company profiles for major industry participants 2016-2021
A latest report by Marketdataforecast.com on Global Prostate Cancer Market provides information on market size, share, forecast and company profiles for major industry participants 2016-2021
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
RESEARCH REPORT<br />
MAR 2017<br />
GLOBAL PROSTATE CANCER MARKET<br />
SEGMENTED BY TYPE AND REGION-INDUSTRY ANALYSIS, SIZE,<br />
SHARE, GROWTH TRENDS AND FORECASTS <strong>2016</strong>-<strong>2021</strong>
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong><br />
According <strong>to</strong> the report "<strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong>", published by <strong>Market</strong> D<strong>at</strong>a Forecast, the global<br />
market is projected <strong>to</strong> reach USD 75.56 Billion by <strong>2021</strong>, <strong>at</strong> a <strong>CAGR</strong> of <strong>9.5%</strong> <strong>from</strong> <strong>2016</strong> <strong>to</strong> <strong>2021</strong>.<br />
<strong>Prost<strong>at</strong>e</strong> cancer is cancer which occurs in a man’s prost<strong>at</strong>e. It is one of the most widespread types of<br />
cancer in men. <strong>Prost<strong>at</strong>e</strong> cancer is a commercially profitable indic<strong>at</strong>ion with a high amount of diagnosis<br />
incidences. New products inventions, partnership agreements, collabor<strong>at</strong>ions and acquisitions are<br />
some key str<strong>at</strong>egies adopted by the players <strong>to</strong> get large market share in the forecast period.<br />
Advancement in technology, personalized medicine, cost effective tre<strong>at</strong>ment procedures are few<br />
other fac<strong>to</strong>rs expected provide boost <strong>to</strong> global prost<strong>at</strong>e cancer market. The market <strong>grow</strong>th would<br />
turn around the novel breakthrough tre<strong>at</strong>ments accountable for reaping survival benefits. The<br />
survival benefit would be instrumental in leading the peak sales and market penetr<strong>at</strong>ion of novel<br />
approved drugs.<br />
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong> is segmented by Diagnostic Techniques, Surgery, Radi<strong>at</strong>ion<br />
Therapy, Chemotherapy and region.<br />
1. By Diagnostic Techniques:<br />
<br />
<br />
Digital Rectal Exam (DRE)<br />
<strong>Prost<strong>at</strong>e</strong> Specific Antigen Test (PSA)<br />
2. By Surgery:<br />
<br />
<br />
<br />
Radical <strong>Prost<strong>at</strong>e</strong>c<strong>to</strong>my<br />
Orchidec<strong>to</strong>my<br />
Trans Urethral Resection (TUR)<br />
3. By Radi<strong>at</strong>ion Therapy:<br />
<br />
<br />
External Beam Radi<strong>at</strong>ion Therapy<br />
a) 3D Conformal Radi<strong>at</strong>ion Therapy<br />
b) Intensity Modul<strong>at</strong>ed Radi<strong>at</strong>ion Therapy<br />
c) Stereotactic Body Radi<strong>at</strong>ion Therapy<br />
d) Pro<strong>to</strong>n Beam Radi<strong>at</strong>ion Therapy<br />
Brachytherapy<br />
a) Permanent Brachytherapy<br />
b) Temporary Brachytherapy<br />
4. By Chemotherapy:<br />
<br />
<br />
<br />
<br />
<br />
Docetaxel<br />
E<strong>to</strong>poside<br />
Vinblastine<br />
Carbopl<strong>at</strong>in<br />
Vinorelbine<br />
5. By Geography:<br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong><br />
<br />
<br />
<br />
<br />
<br />
North America<br />
Europe<br />
Asia-Pacific<br />
L<strong>at</strong>in America<br />
Middle-East and Africa<br />
Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems,<br />
Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Labora<strong>to</strong>ries, and<br />
Genentech etc.<br />
TABLE OF CONTENTS<br />
1.Introduction<br />
1.1 <strong>Market</strong> Definition<br />
1.2 Study Deliverables<br />
1.3 Base Currency, Base Year and Forecast Periods<br />
1.4 General Study Assumptions<br />
2. Research Methodology<br />
3. Overview<br />
2.1 Introduction<br />
2.2 Research Phases<br />
2.2.1 Secondary Research<br />
2.2.2 Primary Research<br />
2.2.3 Econometric Modelling<br />
2.2.4 Expert Valid<strong>at</strong>ion<br />
2.3 Analysis Design<br />
2.4 Study Timeline<br />
3.1 Executive Summary<br />
3.2 Key Inferences<br />
3.3 Epidemology<br />
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />
4.1 <strong>Market</strong> Drivers<br />
4.2 <strong>Market</strong> Restraints<br />
4.3 Key Challenges<br />
4.4 Current Opportunities in the <strong>Market</strong><br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong><br />
5. <strong>Market</strong> Segment<strong>at</strong>ion<br />
5.1 Diagnostic Techniques<br />
5.1.1 Introduction<br />
5.1.2 Digital Rectal Exam (DRE)<br />
5.1.3 <strong>Prost<strong>at</strong>e</strong> Specific Antigen Test (PSA)<br />
5.1.4 Y-o-Y Growth Analysis, By Product<br />
5.1.5 <strong>Market</strong> Attractiveness Analysis, By Product<br />
5.1.6 <strong>Market</strong> Share Analysis, By Product<br />
View Report <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-prost<strong>at</strong>e-cancermarket-1616/<br />
5.2 Surgery<br />
5.2.1 Introduction<br />
5.2.2 Radical <strong>Prost<strong>at</strong>e</strong>c<strong>to</strong>my<br />
5.2.3 Orchidec<strong>to</strong>my<br />
5.2.4 Trans Urethral Resection (TUR)<br />
5.2.5 Y-o-Y Growth Analysis, By Type<br />
5.2.6 <strong>Market</strong> Attractiveness Analysis, By Type<br />
5.2.7 <strong>Market</strong> Share Analysis, By Type<br />
Get free sample report <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-prost<strong>at</strong>ecancer-market-1616/request-sample<br />
5.3 Radi<strong>at</strong>ion Therapy<br />
5.3.1 Introduction<br />
5.3.2 External Beam Radi<strong>at</strong>ion Therapy<br />
5.3.3 Brachytherapy<br />
5.3.4 Y-o-Y Growth Analysis, By Applic<strong>at</strong>ion<br />
5.3.5 <strong>Market</strong> Attractiveness Analysis, By Applic<strong>at</strong>ion<br />
5.3.6 <strong>Market</strong> Share Analysis, By Applic<strong>at</strong>ion<br />
5.4 Chemotherapy<br />
5.4.1 Introduction<br />
5.4.2 Docetaxel<br />
5.4.3 E<strong>to</strong>poside<br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong><br />
5.4.4 Vinblastine<br />
5.4.5 Carbopl<strong>at</strong>in<br />
5.4.6 Vinorelbine<br />
Request Cus<strong>to</strong>miz<strong>at</strong>ion <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-prost<strong>at</strong>ecancer-market-1616/cus<strong>to</strong>mize-report<br />
6. Geographical Analysis<br />
6.1 Introduction<br />
5.4.7 Y-o-Y Growth Analysis, By Disease Indic<strong>at</strong>ions<br />
5.4.8 <strong>Market</strong> Attractiveness Analysis, By Disease Indic<strong>at</strong>ions<br />
5.4.9 <strong>Market</strong> Share Analysis, By Disease Indic<strong>at</strong>ions<br />
Enquire before buying <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-prost<strong>at</strong>ecancer-market-1616/inquire<br />
6.1.1 Regional Trends<br />
6.1.2 Impact Analysis<br />
6.1.3 Y-o-Y Growth Analysis<br />
6.1.4 <strong>Market</strong> Attractiveness Analysis<br />
6.1.5 <strong>Market</strong> Share Analysis<br />
6.2 North America<br />
6.1.1 Introduction<br />
6.1.2 United St<strong>at</strong>es<br />
6.1.3 Canada<br />
Buy this report <strong>at</strong> https://www.marketd<strong>at</strong>aforecast.com/cart/buy-now/global-prost<strong>at</strong>e-cancermarket-1616<br />
6.3 Europe<br />
6.2.1 Introduction<br />
6.2.2 U.K<br />
6.2.3 Spain<br />
6.2.4 Germany<br />
6.2.5 Italy<br />
6.2.6 France<br />
6.4 Asia-Pacific<br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong><br />
6.3.1 Introduction<br />
6.3.2 China<br />
6.3.3 India<br />
6.3.4 Japan<br />
6.3.5 Australia<br />
6.3.6 South Korea<br />
6.5 L<strong>at</strong>in America<br />
6.4.1 Introduction<br />
6.4.2 Brazil<br />
6.4.3 Argentina<br />
6.4.4 Mexico<br />
6.4.5 Rest of L<strong>at</strong>in America<br />
6.6 Middle East & Africa<br />
6.5.1 Introduction<br />
6.5.2 Middle-East<br />
6.5.3 Africa<br />
7.Str<strong>at</strong>egic Analysis<br />
7.1 PESTLE analysis<br />
7.1.1 Political<br />
7.1.2 Economic<br />
7.1.3 Social<br />
7.1.4 Technological<br />
7.1.5 Legal<br />
7.1.6 Environmental<br />
7.2 Porter’s Five analysis<br />
7.2.1 Bargaining Power of Suppliers<br />
7.2.2 Bargaining Power of Consumers<br />
7.2.3 Thre<strong>at</strong> of New Entrants<br />
7.2.4 Thre<strong>at</strong> of Substitute Products and Services<br />
7.2.5 Competitive Rivalry within the Industry<br />
8.<strong>Market</strong> Leaders' Analysis<br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong><br />
8.1 Sanofi S.A<br />
8.1.1 Overview<br />
8.1.2 Product Analysis<br />
8.1.3 Financial analysis<br />
8.1.4 Recent Developments<br />
8.1.5 SWOT analysis<br />
8.1.6 Analyst View<br />
8.2 GlaxoSmithKline<br />
8.3 AstraZeneca<br />
8.4 AbbVie<br />
8.5 Varian Medical Systems<br />
8.6 Elekta<br />
8.7 Theragenics<br />
8.8 Pfizer<br />
8.9 Novartis<br />
9.Competitive Landscape<br />
9.1 <strong>Market</strong> share analysis<br />
9.2 Merger and Acquisition Analysis<br />
9.3 Agreements, collabor<strong>at</strong>ions and Joint Ventures<br />
9.4 New Product Launches<br />
10.<strong>Market</strong> Outlook and Investment Opportunities<br />
Appendix<br />
a) List of Tables<br />
b) List of Figures<br />
For more rel<strong>at</strong>ed reports <strong>from</strong> Therapeutics segment:<br />
Au<strong>to</strong>immune Monoclonal Antibodies <strong>Market</strong>: http://www.marketd<strong>at</strong>aforecast.com/marketreports/global-au<strong>to</strong>immune-monoclonal-antibodies-1170/<br />
<strong>Cancer</strong> Immunotherapy <strong>Market</strong>: http://www.marketd<strong>at</strong>aforecast.com/market-reports/globalcancer-immunotherapy-market-1412/<br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
<strong>Global</strong> <strong>Prost<strong>at</strong>e</strong> <strong>Cancer</strong> <strong>Market</strong><br />
SCOPE OF THE REPORT<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<strong>Global</strong>, regional and country-level analysis and forecasts of the study market; providing<br />
Insights on the major countries/regions in which this industry is blooming and <strong>to</strong> also identify<br />
the regions th<strong>at</strong> are still untapped<br />
Segment-level analysis in terms of technology, component, and type along with market <strong>size</strong><br />
forecasts and estim<strong>at</strong>ions <strong>to</strong> detect key areas of industry <strong>grow</strong>th in detail<br />
Identific<strong>at</strong>ion of key drivers, restraints, opportunities, and challenges (DROC) in the market<br />
and their impact on shifting market dynamics<br />
Study of the effect of exogenous and endogenous fac<strong>to</strong>rs th<strong>at</strong> affect the global market; which<br />
includes broadly demographic, economics, and political, among other macro-environmental<br />
fac<strong>to</strong>rs presented in an extensive PESTLE Analysis<br />
Study the micro environment fac<strong>to</strong>rs th<strong>at</strong> determine the overall profitability of an Industry,<br />
using Porter’s five forces analysis for analyzing the level of competition and business str<strong>at</strong>egy<br />
development<br />
A comprehensive list of key market players along with their product portfolio, current<br />
str<strong>at</strong>egic interests, key financial inform<strong>at</strong>ion, legal issues, SWOT analysis and analyst<br />
overview <strong>to</strong> study and sustain the market environment<br />
Competitive landscape analysis listing out the mergers, acquisitions, collabor<strong>at</strong>ions in the<br />
field along with new product launches, compar<strong>at</strong>ive financial studies and recent<br />
developments in the market by the major companies<br />
An executive summary, abridging the entire report in such a way th<strong>at</strong> decision-making<br />
personnel can rapidly become acquainted with background inform<strong>at</strong>ion, concise analysis and<br />
main conclusions<br />
Expertly devised analyst overview along with Investment opportunities <strong>to</strong> provide both<br />
individuals and organiz<strong>at</strong>ions a strong financial foothold in the market<br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
ABOUT US<br />
<strong>Market</strong> D<strong>at</strong>a Forecast is a firm working in the areas of market research<br />
and business intelligence. We have rich experience in research across<br />
various business domains and we c<strong>at</strong>er <strong>to</strong> the needs of both individual<br />
and corpor<strong>at</strong>e clients. Our research services assist clients in key<br />
business areas like business process improvement, key decision<br />
making and developing appropri<strong>at</strong>e corpor<strong>at</strong>e str<strong>at</strong>egy. We are truly<br />
committed <strong>to</strong> our clients and other stakeholders for providing<br />
cus<strong>to</strong>mized research services of the highest quality.<br />
CONTACT INFORMATION<br />
We always look forward <strong>to</strong> working with new clients, pushing our<br />
boundaries and extending our reach beyond global horizons. Get in<br />
<strong>to</strong>uch with us for further queries.<br />
Website: www.marketd<strong>at</strong>aforecast.com<br />
E-Mail: contact@marketd<strong>at</strong>aforecast.com<br />
Phone: +1 888-702-9626 (U.S Toll free),<br />
+91 7680952236 (Indian Office).<br />
FOR MORE INFORMATION<br />
+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com
Change language